NVX-CoV2373
Novavax COVID-19 vaccine works, but less so against variants
Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work- though not as well- against new mutated versions of the virus circulating in that country and South Africa.